Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Operating Margin (2020 - 2025)

Historic Operating Margin for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 27.35%.

  • Harmony Biosciences Holdings' Operating Margin fell 58200.0% to 27.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.32%, marking a year-over-year increase of 16100.0%. This contributed to the annual value of 26.7% for FY2024, which is 62900.0% down from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Operating Margin stood at 27.35% for Q3 2025, which was down 58200.0% from 24.03% recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Operating Margin high stood at 40.25% for Q3 2023, and its period low was 10.15% during Q3 2022.
  • In the last 5 years, Harmony Biosciences Holdings' Operating Margin had a median value of 30.94% in 2022 and averaged 28.72%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 727900bps in 2021, then crashed by -225900bps in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Operating Margin (Quarter) stood at 31.39% in 2021, then grew by 18bps to 37.11% in 2022, then crashed by -36bps to 23.87% in 2023, then grew by 16bps to 27.69% in 2024, then decreased by -1bps to 27.35% in 2025.
  • Its last three reported values are 27.35% in Q3 2025, 24.03% for Q2 2025, and 30.45% during Q1 2025.